Firefighters attended suspicious boat fires at the Outboard Boating Club on Tamaki Dr, Auckland last night. A scene guard is in place and police investigation under way after three boats in a ...
Bryan Johnson has dropped the medicine he had been taking for last five years. Bryan Johnson, the 47-year-old tech entrepreneur who has spent millions on his quest to reverse his biological age ...
Nintendo has unveiled the long-awaited successor to its popular Switch video game console: the Nintendo Switch 2. First-look images at the console design and a teaser trailer were revealed by ...
Anti-aging advocate Bryan Johnson, who gulps down 54 pills for breakfast, recently discovered a wrinkle in his meticulous approach to dodging death. Every two weeks, the 47-year-old tech ...
The Nintendo Switch 2 has just been officially revealed, and its announcement mercifully officially confirmed the rumors that it would be mostly fully backward compatible with Nintendo Switch 1 games.
Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...
Rep. Thomas Massie, one of the most outspoken critics of House Speaker Mike Johnson, is off the powerful House Rules Committee, which plays a critical role in the functioning of the lower chamber ...
Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...
It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...
(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...
The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.
Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...